Skip header and navigation

Refine By

13 records – page 1 of 2.

Pertussis Antigen vials

https://mhc.andornot.com/en/permalink/artifact8768
Dates
1938
circa 1938
Collection
University Health Network - Academy of Medicine Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectiious Diseases
Vaccination
Accession Number
1997.2.7
Description
A cardboard box wrapped around with printed labels describing contents and usage; contains vials of pertussis (whooping cough) antigen; unopened.
  1 image  
Accession Number
1997.2.7
Collection
University Health Network - Academy of Medicine Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectiious Diseases
Vaccination
MeSH Heading
Drugs
Antigens
Pertussis Vaccine
Vaccination
Immunization
Whooping Cough -- drug therapy
MM= Drug Packaging -- container -- vial
Description
A cardboard box wrapped around with printed labels describing contents and usage; contains vials of pertussis (whooping cough) antigen; unopened.
Number Of Parts
1
Provenance
Acquired from the Academy of Medicine; source: Dr. H.B. Rundle (1911-1997) via Mr. Howard Rundle.
Maker
Lederle Laboratories Inc.
Site Made (City)
New York
Site Made (State)
New York
Site Made (Country)
United States of America
Dates
1938
circa 1938
Material
cardboard
paper: off-white
ink: black
glass
liquid
Inscriptions
Printed on box: "3 vials 2 cc. size // PERTUSSIS ANTIGEN // (DETOXIFIED) // Lederle (in cursive script) // BACTERIAL ANTIGEN MADE FROM // Pertussis Bacillus"
Permanent Location
Storage Room 0010
0010-A2-4 Row F
Temporary Location
On display: "Vaccines and Immunization: Epidemics, Prevention, and Canadian Innovation"; Museum of Health Care, Nov. 28, 2013.
Dimension Notes
Length 5.7 cm x Width 4.0 cm x Depth 2.4 cm
Condition Remarks
Label intact; stained and discoloured.
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #UHN
Images
Less detail

animal vaccine injector kit

https://mhc.andornot.com/en/permalink/artifact4068
Dates
1931
circa 1931
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
Accession Number
000001275 a-g
Description
Kit consists of (a) a cardboard box and (b) its lid, (c) the injector syringe: a metal barrel with a needle tip; inside the barrel is a spring-loaded plunger to push the pellet through the needle; spring is coiled and sprung by means of a metal knob on the side of the barrel that moves through a ho…
  1 image  
Accession Number
000001275 a-g
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
MeSH Heading
Vaccines
Veterinary Drugs
Syringes
Injections -- instrumentation
Vaccination
MM= Drugs -- vaccines -- container
MM= Injections -- accessories
MM= Drug Packaging -- container -- vial
Description
Kit consists of (a) a cardboard box and (b) its lid, (c) the injector syringe: a metal barrel with a needle tip; inside the barrel is a spring-loaded plunger to push the pellet through the needle; spring is coiled and sprung by means of a metal knob on the side of the barrel that moves through a hole cut in the barrel for that purpose; (d) a metal tube that serves as a cap for the needle, (e) a cylindrical plastic vial, stopped with a cork and wrapped in a paper label with one pellet inside, (f) a paper notice, and (g) an instruction leaflet; box is lined with crumpled tissue paper that has not been given an accession number.
Number Of Parts
7
Part Names
a - box bottom - Size: Length 18.0 cm x Width 3.4 cm x Depth 3.3 cm
b - box lid - Size: Length 18.3 cm x Width 3.8 cm x Depth 3.4 cm
c - syringe - Size: Length 14.8 cm x Diam. 2.1 cm
d - cap - Size: Length 4.1 cm x Diam. 0.6 cm
e - vial - Size: Length 2.2 cm x Diam. 0.6 cm
f - notice - Size: Length 7.7 cm x Width 4.1 cm
g - leaflet (unfolded) - Size: Length 17.3 cm x Width 10.6 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co., Ltd.
Site Made (City)
Walkerville
Site Made (State)
Ontario
Site Made (Country)
Canada
Dates
1931
circa 1931
Date Remarks
Based on lot number
Material
cork: brown
paper: white; beige; black; blue
metal: silver
cardboard: brown; grey
plastic: translucent yellow
Inscriptions
(a) Bottom: "MADE IN U.S.A. [stamped]"; (b) left side: "Animal Vaccine // INJECTOR // Syringe No. 17 // C779206 [stamped] // PARKE DAVIS & CO [engraved]"; (e) "BLACKLEG VACCINE // SINGLE Dose: 1 Oid. // Use // before June 1935 // C691502 // PARKE, DAVIS & Co."; (f) "NOTICE // When the syringe was packed it was examined and // found to be in perfect order, and should reach you // in that condition. We cannot, therefore, hold our- // selves resposible for any injury which may occur // to the instrument after its receipt. We do not // accept any syringe for credit or exchange after it // has been used. // PARKE, DAVIS & CO., Ltd."; (g) "How to Use the Animal // Vaccine Injector // [text follows] // TO PREVENT THE SPREAD OF INFECTION // [text follws] // PARKE, DAVIS & CO., LTD. // WALKERVILLE, ONTARIO"
Permanent Location
Storage Room 0010
0010-A3-4 Row D
Condition Remarks
Water mark on box bottom and bottom edge of box top; corners of box top scuffed, dented; no corrosion on syringe or cap; paper label on vial yellowing; vial lip broken, with a piece missing; cork still fits securely; paper leaflets are yellowed
Copy Type
Original
Reference Types
Document
Reference Comments
Parke-Davis Lot Numbering System
Images
Less detail
Dates
1975
circa 1975
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001281 a-c
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
  1 image  
Accession Number
000001281 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Company
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1975
circa 1975
Date Remarks
Based on expiry date
Material
glass: clear
paper: white; blue; black
cardboard: white; blue
plastic: blue
metal: silver
rubber: pink
Inscriptions
(a) Front: "5 ML. Bio. 1568 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1973-74 season. // Stock 4-1568-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 1000 CCA units per human dose (0.5 // ml.) in the recommended ratio of 700 CCA units of the A // influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injections // of 0.5 ml. each, given at least two months apart. See // package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propogated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1568 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] Feb. 1, 1975 // 903033B [stamped]"; (b) front: "C // 5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains no less than 1000 CCA units per human dose // (0.5 ml.) in the recommended ratio of 700 CCA units of the A influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – Two // intramuscular injections of 0.5 // ml. each, given at least two months apart. See package // inssert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp Date and Lot [printed] // Feb. 1, 1975 // 903033B [stamped]"; bottom: "W // 83 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "C // FLUOGEN® // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 877800 C-PO // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from DESCRIPTION] // INDICATIONS // [text follows] // 121 877800 2 C - PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from INDICATIONS] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 121 877800 3 C-PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 877800 //Parke, Davis & Co. // Detroit, Mi 48232 USA C-PD // A // Issued Aprile 1973 [French translation appears alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Condition Remarks
Box somewhat dirty, dented; no apparent problems wtih vial or leaflet
Copy Type
Original
Reference Types
Other
JPG
Reference Comments
See also 000.001.282; CD #8
Images
Less detail
Dates
1974
circa 1974
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001282 a-c
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
  1 image  
Accession Number
000001282 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Company
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1974
circa 1974
Date Remarks
Based on expiry date
Material
glass: clear
paper: white; blue; black
cardboard: white; blue
plastic: blue
metal: silver
rubber: pink
Inscriptions
(a) Front: "5 ML. Bio. 1568 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1973-74 season. // Stock 4-1568-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 1000 CCA units per human dose (0.5 // ml.) in the recommended ratio of 700 CCA units of the A // influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injections // of 0.5 ml. each, given at least two months apart. See // package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propogated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1568 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] Nov. 15, 1974 // 903028C [stamped]"; (b) front: "C // 5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains no less than 1000 CCA units per human dose // (0.5 ml.) in the recommended ratio of 700 CCA units of the A influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – Two // intramuscular injections of 0.5 // ml. each, given at least two months apart. See package // inssert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp Date and Lot [printed] // Nov. 15, 1974 // 903028C [stamped]"; bottom: "W // 91 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "C // FLUOGEN® // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 877800 C-PO // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from DESCRIPTION] // INDICATIONS // [text follows] // 121 877800 2 C - PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from INDICATIONS] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 121 877800 3 C-PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 877800 //Parke, Davis & Co. // Detroit, Mi 48232 USA C-PD // A // Issued Aprile 1973 [French translation appears alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Condition Remarks
Box somewhat dirty, dented; no apparent problems wtih vial or leaflet
Copy Type
Original
Reference Types
Other
JPG
Reference Comments
See also 000.001.281; CD #8
Images
Less detail

Influenza Virus Vaccine

https://mhc.andornot.com/en/permalink/artifact4076
Dates
1969
circa 1969
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001283 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over vial neck and lip; vial is in a cardboard box (a) with a paper leaflet (c); there is a square white sticker on left side of box
  1 image  
Accession Number
000001283 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Influenza
Vaccination
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over vial neck and lip; vial is in a cardboard box (a) with a paper leaflet (c); there is a square white sticker on left side of box
Number Of Parts
3
Part Names
a - box - Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Length 5.2 cm x Diam. 2.6 cm
c - leaflet (unfolded) - Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis.
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1969
circa 1969
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; red; blue; black
cardboard: white; blue; red; black
rubber: pink
glass: clear
Inscriptions
(a) Front: "10 CC. Bio. 844 // INFLUENZA VIRUS VACCINE, // BIVALENT // C // Contains: A2 //Japan/170/62, A2 // Taiwan/1/64 // and B/Massachusetts/3/66 strains. // BIVALENT // Stock 4-844-1-70 // PARKE-DAVIS"; bottom: "Standardized according to the U.S. Public Health // Service requirements for the 1968-69 season. // Contains 0.01% thymersal (mercury derivative). // Store at temperature between 2° and 8° C. // (35.6° and 46.4° F.). // FREEZING DESTROYS POTENCY"; back: "Prepared from the refined extra-embryonic fluid of // the chick embryo, killed by ultraviolet irradiation // and formalin, and absorbed on aluminum phosphate. // U.S. Licence No. 1 // Canadian Licence no. 1"; top: "SHAKE WELL BEFORE USING // USUAL ADULT DOSE – Two intramuscular injec- // tions of 1 cc. each, given at least two months // apart. See package insert. // Parke, Davis & Company // Detroit, Michigan, U.S.A. 48232"; right side: "10 CC. Bio. 844 // INFLUENZA // VIRUS VACCINE, // BIVALENT // Parke, Davis & Co. // Expiration Date and Lot // NOV 15, 1969 // 985259B"; left side: "10 CC. Bio. 844 // INFLUENZA // VIRUS VACCINE, // B1 [illeg.] // Pa [illeg.] Co. // S [illeg.]"; (b) front: "C 10 CC. Bio. 844 // INFLUENZA VIRUS VACCINE, // BIVALENT // Contains: A2 // Japan/170/62, A2 /Taiwan/64 // and B/Massachusetts/3/66 strains. // Standardized according to the U.S. Public // Health Service requirements for the // 1968-69 season. // BIVALENT // PARKE, DAVIS & CO. DETROIT, Mich., U.S.A."; back: "USUAL ADULT DOSE // Two intramuscular in- // jections of 1 cc. each, // given at least two months // apart. See package // insert. // SHAKE WELL // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Expiration date and Lot // Nov. 15, 1969 // 985259B "; bottom: "NT I // K // 10 // U.S.A."; (c) "C // INFLUENZA VIRUS VACCINE // BIVALENT POLYVALENT // PARKE-DAVIS // Beginning with the 1967-68 season, Influenza Virus // Vaccine is supplied in two formulas: // [text follows] // INDICATIONS // [text follows] // HB // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 2 // HB // [text continues from Adverse Reactions] // ADMINISTRATION AND DOSAGE // [text follows] // 3 // HB // [text continues from Administration] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // PARKE, DAVIS [logo, see sketch on accession sheet] & COMPANY // 121 856750 // K - 97 - A DETROIT, MICHIGAN, U.S.A. HB // Issued Mar. 1968 [French translation accompanies English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Temporary Location
On loan to Museum of Health Care Education Department for Seniors’ Learning Program 22 Aug 2016.
Condition Remarks
Box somewhat yellowed, dented, dirty; leaflet mottled with a yellow stain throughout; no apparent problems with vial
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail

Influenza Virus Vaccine vial

https://mhc.andornot.com/en/permalink/artifact4077
Dates
1981
circa 1981
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001284 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lipwith a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (…
  1 image  
Accession Number
000001284 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Influenza
Vaccination
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lipwith a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1981
circa 1981
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; blue; black
cardboard: white; blue; black
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "DIN 248991 Stock 4-4079-63-70 // INFLUENZA VIRUS VACCINE, // TRIVALENT, TYPES A AND B // FLUOGEN® Subvirion Vaccine // Dose – Persons 27 years and older, a single injection of 0.5 ml; // persons 3 years through 26 years, 2 injections of 0.5 ml, 4 or // more weeks apart; persons 6 months through 35 months, 2 // injections of 0.25 ml, 4 or more weeks apart. Inject // intramuscularly. See package insert. // 5 ml PARKE-DAVIS"; bottom: "Standardized according to 1979-80 NACI and US PHS requirements. // Contains no less than 21 micrograms of HA antigen content per // 0.5 ml dose in the recommended ratio of 7µg of HA of the A // influenza virus component representative of A/Brazil/78 (H1N1), 7 // µg of HA of the A influenza virus component representative of // A/Texas/1/77 (H3N2), and 7µg of HA of the B influenza virus component representative of B/Hong Kong/5/72. The vaccine is of chick embryo origin. // Polysorbate 80, USP, added during manufacture. // Preservative: 0.01% thimer- // osal (mercury derivative). //Store at temperature between // 2° and 8° C (36° and 46° F). // Freezing destroys potency. // Exp date and lot [printed] // FEB. 5, 1981 // YH601 [stamped]"; back: front repeated in French; top: bottom repeated in French up to and including "Freezing destroys potency"] // Permis US n°1 Permis can. n°1 // Parke, Davis & Co/Detroit, Mi 48232 USA"; right side: "5 ml // FLUOGEN // U.S. Lic. No. 1 Can. Lic. No. 1 // PARKE-DAVIS"; left side: "5 ml // FLUOGEN // Stock 4-4079-63-70 // PARKE-DAVIS // Printed in USA // 120 // 457217"; (b) front: "DIN 248991 C // INFLUENZA VIRUS VACCINE, TRIVALENT // TYPES A AND B FLUOGEN® Subvirion // Vaccine // [contents as listed on box front] // The vaccine is of chick embryo origin. // 5 ml PARKE-DAVIS"; back: "LOT YH607 [stamped] // Dose – See package insert. // Standardized according to // the NACI and the US PHS // requirements for the // 1979-80 season. // Stock 4-4079-63-70 // U.S. Lic. No. 1 Can Lic. No. 1 [printed] // EXP FEB. 5, 1981 [stamped] // Parke, Davis & Co // Detroit, Mi 48232 USA // 02 4079 70 1 [printed]"; bottom: "W // 79 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "FLUOGEN® // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // Subvirion Vaccine/Immunizing Antigen, Ether Extracted // DESCRIPTION // [text follows] // ACTION // [text follows] // PARKE-DAVIS // 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Action] // INDICATIONS // 2 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // WARNING // [text follows] // PRECAUTIONS // [text follows] // USAGE IN PREGNANCY // [text follows] // ADVERSE REACTIONS // 3 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Adverse Reactions] // DOSAGE AND ADMINISTRATION // [text follows] // STORAGE // [text follows] // PACKAGE INFORMATION // [text follows] // Unpublished data available upon request. // Issued June 1979 // Parke, Davis & Co., Detroit, Mi 48232 USA 121 887150/C-KF // [French translation accompanies English text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box somewhat yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail
Dates
1975
circa 1975
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001285 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper …
  1 image  
Accession Number
000001285 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Vaccination
Influenza
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1975
circa 1975
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; red; black
cardboard: white; blue; red
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "5 ML. Bio. 1600 // FLUOGEN®-B // Standardized according to the U.S. Public // Health Service requirements for the 1973-74 season. // Stock 4-1600-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // PARKE, DAVIS & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1600 // INFLUENZA VIRUS VACCINE, MONVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 500 CCA units per human dose // (0.5 ml.) of a type B influenza virus strain representative of // B/Hong Kong /5/72. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – One intramuscular injection of // 0.5 ml. See package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propagated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1600 // FLUOGEN®-B // PARKE-DAVIS [printed] // Exp. Date and Lot // Feb. [stamped] 75 [handwritten] // 903619A [stamped] // 120 // 455817 [printed]"; (b) front: "5 ML. Bio. 1600 // INFLUENZA VIRUS VACCINE MONOVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN®-B // Contains no less than 500 CCA units per human // dose (0.5 ml.) of a type B influenza virus strain // representative of B/Hong Kong/5/72. // Parke, Davis & Co/Detroit, Mi 48232 USA C [printed] // USUAL ADULT DOSE – One // intramuscular injection of 0.5 // ml. See package insert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp. Date and Lot [printed] // Feb. 5, 1975 // 903619A [stamped]"; bottom: "W // 88 [embossed]"; top: "FLIP // OFF [embossed]"; (c) FLUOGEN®-B // INFLUENZA VIRUS VACCINE, MONOVALENT // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 878100 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from Description] // INDICATIONS // [text follows] // 121 878100 2 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // 121 878100 2 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // ADVERSE REACTIONS // [text follows] // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 878100 // PARKE, DAVIS & Co // Detroit Mi 48232 USA // A // Issued June 1973 // C-PF // [French translation accompanies English, alongside text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail

influenza virus vaccine vial

https://mhc.andornot.com/en/permalink/artifact4079
Dates
1970
circa 1970
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001286 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is removed, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper lea…
  5 images  
Accession Number
000001286 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Influenza
Vaccination
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is removed, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c); there is a square sticker on the box back.
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 5.2 cm x Diam. 2.6 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Company
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1970
circa 1970
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; blue; black
ink: blue; black
cardboard: white; blue
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "10 CC. Bio. 669 // INFLUENZA VIRUS VACCINE, // MONOVALENT // C Contains: A2 ["2" subscr.]/Aichi/2/68 strain // (Hong Kong Variant) // Each 1 cc. contains 400 CCA units. // Stock 4-669-1-70 // PARKE-DAVIS"; bottom: "U.S. Licence No. 1. // Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (35.6° and 46.4° F.). // FREEZING DESTROYS POTENCY"; back: "Prepared from the refined extra-embryonic fluid of // the chick embryo, killed [illeg.] iolet irra- // diation and formalin. A [illeg.] is added // as a [illeg.] // Contains 0.01% thimerosal [illeg.] derivative). [printed] // JA // 2 // WHIT [stamped on sticker]"; top: "SHAKE WELL BEFORE USING // USUAL ADULT DOSE – 1 cc. intramuscularly. // See package insert. // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; right side: "10 CC. Bio. 669 // INFLUENZA // VIRUS VACCINE, // MONOVALENT // Parke, Davis & Co. // Expiration Date and Lot // June 25, 1970 // 988124 B"; left side: "10 CC. Bio. 669 // INFLUENZA // VIRUS VACCINE, // MONOVALENT // Parke, Davis & Co. // Stock 4-669-1-70 // 2 // SFB"; (b) front: "C // 10 CC. Bio. 669 // INFLUENZA VIRUS VACCINE, // MONOVALENT // Each 1 cc. contains 400 CCA // units of A2 ["2" subscr.]/Aichi/2/68 // strain (Hong Kong // Variant) // PARKE, DAVIS & CO. DETROIT, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – // 1 cc. intramuscularly. // See package insert. // SHAKE WELL // BEFORE USING // U.S. Licence No. 1. // Canadian Licence No. 1. // Expiration date and Lot // June 25, 1970 // 988124B"; bottom: "NTI // K // 21 // U.S.A. [embossed]"; top: "FLIP // OFF [embossed]; (c) C // INFLUENZA VIRUS VACCINE, MONOVALENT // Type A2 ["2" subscr.], Aichi Strain (Hong Kong Variant) // PARKE-DAVIS // DESCRIPTION // [text follows] // INDICATIONS // [text follows] // CONTRAINDICATIONS // [text follows] // HL // [text continues from Contraindications] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // PARKE, DAVIS [logo, see sketch on accession sheet] & COMPANY // 121 865350 // K-26-27 DETROIT, MICHIGAN, U.S.A. HL // Issued Nov. 1968"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Comments
Wikipedia "Hong Kong Flu"
Research Facts
Made for the Hong Kong Flu (H3N2) of 1968-1969, which killed approximately one million people worldwide.
Images
Less detail
Dates
1983
circa 1983
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001287 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over the vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is removed, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper l…
  1 image  
Accession Number
000001287 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over the vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is removed, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke-Davis Canada Inc.
Dates
1983
circa 1983
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; blue; black
cardboard: white; blue; black
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "DIN 248991 // Fluogen* // Subvirion Vaccine // Influenza Virus Vaccine. // Trivalent, Types A and B // Dosage – Persons 13 years and older, // a single injection of 0.5 mL; persons // 3 years through 12 years, 2 injections // of 0.5 mL, 4 or more weeks apart; // persons 6 months through 35 months, // 2 injections of 0.25 mL, 4 or more // weeks apart. Inject intramuscularly. // See package insert. // 5 mL // PARKE-DAVIS"; right side: "Contains no less than 45 micrograms // of HA antigen content per 0.5 mL // dose in the recemmended ratio of 15 // µg of HA of the A influenza virus // component represen- // tative of A/Bangkok/1/79 (H3N2) // and 15 µg of HA of the B influenza // virus component representative of // B/Singapore/222/79. The vaccine is / of chick embryo origin. Polysorbate // 80 NF, added during manufacture. // Preservative: 0.01% thimerosal (mer- // cury derivative). Standardized accord- // ing to the 1982-83 NACI and US // PHS requirements. // *Reg. T.M. / M. Enr. Parke, Davis & Company // Parke-Davis Canada Inc. // auth. user / usager aut. // Can. Lic. No. 1 [printed] // (L) 26227 // Exp. JN 1983 [stamped]"; back: front repeated in French; left side: contents as printed on right side repeated in French; "Permis can. n° 1 // Parke-Davis Canada Inc. // Scarborough, Ontario // 266B670 26664"; top: "Store at temperature // between 2° and 8° C // (36° and 46° F) // Freezing destroys // potency. // [above 5 lines repeated in French] // 266B670 26664"; (b) front: "DIN 248991 // Fluogen* // Subvirion Vaccine // Influenza Virus Vaccine, // Trivalent, Types A and B // 5 mL // PARKE-DAVIS"; back: "(L) 26227 // EXP JN 1983 [stamped] // [contents, dosage and storage in English as on box] // Can. Lic. No. 1 // *Reg. T.M. Parke, Davis & Company // PARKE-DAVIS Canada Inc. auth. user // 266H130 26664"; bottom: "W // 37 [embossed]"; top: "FLIP // OFF [embossed]" (c) FLUOGEN* // INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B // Subvirion Vaccine/Immunizing Antigen. // Ether Extracted // DESCRIPTION // [text follows] // CLINICAL PHARMACOLOGY // [text follows] // // 1 // [text continues from Clinical . . .] // INDICATIONS AND USAGE // [text follows] // CONTRAINDICATIONS // [text follows] // 2 // [text continues from Contraindications] // WARNING // [text follows] // PRECAUTIONS // [text follows] // PREGNANCY // [text follows] // ADVERSE REACTIONS // [text follows] // 3 // [text continues from Adverse . . .] // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // *Reg. T.M. / M. Enr. Parke, Davis & Company // Parke-Davis Canada Inc. auth. user / usager aut. // PARKE-DAVIS // 266E940 Parke-Davis Canada Inc., Scarborough, Ontario 26664 // 4 // [French translation occurs alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box somewhat dirty, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail
Dates
1973
circa 1973
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001468 a-b
Description
A cylindrical glass vial (b) inside a cardboard box (a); vial is stopped with a rubber stopper and sealed with a metal cap; a plastic cap covers the metal cap such that when it is pulled off it breaks the seal on the metal cap; vial has a paper label on front and sides and is full of liquid.
  5 images  
Accession Number
000001468 a-b
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
A cylindrical glass vial (b) inside a cardboard box (a); vial is stopped with a rubber stopper and sealed with a metal cap; a plastic cap covers the metal cap such that when it is pulled off it breaks the seal on the metal cap; vial has a paper label on front and sides and is full of liquid.
Number Of Parts
2
Part Names
a - box - Size: Length 5.3 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1973
circa 1973
Date Remarks
Based on expiry date
Material
paper: white; blue
plastic: blue
metal: silver
cardboard: blue; white
rubber: pink
glass: clear
Inscriptions
(a) Front: "5 ML. Bio. 1508 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1972-73 season. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injec- // tions of 0.5 ml. each, given at least two months // apart. See package insert. // [dosage repeated in French] // Prepared from formalin stabilized, zonally cen- // trifuged antigens, ether-extracted from virus // propagated in the extraembryonic fluid of the // chick embryo. // U.S. Patent No. 3,105,012 // Polysorbate 80, U.S.P., added during // manufacture."; back: "5 ML. Bio, 1508 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C // Contains 700 CCA units of A/Aichi/2/68/X-31 (H3N2) // strain (Hong Kong Variant) and 300 CCA units of // B/Massachusetts/1/71 strain in each 0.5-ml. dose. // Stock 4-1508-1-70 // PARKE-DAVIS"; bottom: "Contains 0.01% thimerosal (mercury derivative) // as a preservative. // U.S. Licence No. 1. // Canadian Licence No. 1. // Store at temperature between 2° and 8° C. (36° and 46° F.). // FREEZING DESTROYS POTENCY // SHAKE WELL BEFORE USING // Parke, Davis & Company // Detroit, Michigan 48232 // U.S.A. [printed] // XG YBY [handwritten over printed text]"; right side: "5 ML. Bio. 1508 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] // Dec. 10, 1973 // 900259C [stamped]"; left side: "5 ML. Bio. 1508 // FLUOGEN // Parke, Davis & Co. // Stock 4-1508-1-70 [printed]"; (b) front: "C // 5 ML. Bio. 1508 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains 700 CCA units of A/Aichi/2/68/X-31 (H3N2) // strain (Hong Kong Variant) and 300 CCA units of // B/Massachusetts/1/71 strain in each 0.5-ml. dose. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE–Two // intramuscular injections of 0.5 // ml. each, given at least two // months apart. See package // insert. // Standardized according to the // U.S. Public Health Service // requirements for the 1972-73 season. // U.S. Lic. No. 1. // Canadian Lic. No. 1 // Exp. Date and Lot [printed] // Dec. 10, 1973 // 900259C [stamped]"; bottom: "W // 103 [embossed]"; top: "FLIP // OFF [embossed]"
Permanent Location
Storage Room 0010
0010-A3-7 Row G
Condition Remarks
Box yellowing, dirty, scuffed, torn in two places on the bottom; no apparent problems with vial
Copy Type
Original
Reference Comments
CD #8
Images
Less detail

13 records – page 1 of 2.